Reduction of Secreted Frizzled-Related Protein 5 Drives Vascular Calcification through Wnt3a-Mediated Rho/ROCK/JNK Signaling in Chronic Kidney Disease
Open Access
- 17 May 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (10), 3539
- https://doi.org/10.3390/ijms21103539
Abstract
Vascular calcification (VC) is commonly associated with bone loss in patients with chronic kidney disease (CKD). The Wingless-related integration site (Wnt) regulates osteoblast activation through canonical signaling pathways, but the common pathophysiology of these pathways during VC and bone loss has not been identified. A rat model of adenine-induced CKD with VC was used in this study. The rats were fed 0.75% adenine (2.5% protein, 0.92% phosphate) with or without intraperitoneal injection of calcitriol (0.08 µg/kg/day) for 4 weeks. Angiotensin II (3 µM)-induced VC was achieved in high phosphate medium (3 mM) through its effect on vascular smooth muscle cells (VSMCs). In an mRNA profiler polymerase chain reaction assay of the Wnt signaling pathway, secreted frizzled-related protein 5 (sFRP5) levels were significantly decreased in the CKD rat model compared with the control group. The repression of sFRP5 on VSMC trans-differentiation was mediated through Rho/Rho-associated coiled coil containing protein kinase (ROCK) and c-Jun N-terminal kinase (JNK) pathways activated by Wnt3a. In a proof of concept study conducted with patients with CKD, serum sFRP5 concentrations were significantly lower in subjects with VC than in those without VC. Our findings suggest that repression of sFRP5 is associated with VC in the CKD environment via activation of the noncanonical Wnt pathway, and thus that sFRP5 might be a novel therapeutic target for VC in CKD.Keywords
Funding Information
- Gil Medical Center, Gachon University (2017-13)
- National Research Foundation of Korea (2019R1F1A1057630)
This publication has 63 references indexed in Scilit:
- Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibitionJCI Insight, 2012
- WNT-3A modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathwaysThe Journal of cell biology, 2011
- Generation and Selection of Novel Fully Human Monoclonal Antibodies That Neutralize Dickkopf-1 (DKK1) Inhibitory Function in Vitro and Increase Bone Mass in VivoPublished by Elsevier BV ,2010
- Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in ObesityScience, 2010
- Wnt5a regulates distinct signalling pathways by binding to Frizzled2The EMBO Journal, 2009
- Sfrp5 coordinates foregut specification and morphogenesis by antagonizing both canonical and noncanonical Wnt11 signalingGenes & Development, 2008
- The Netrin-related domain of Sfrp1 interacts with Wnt ligands and antagonizes their activity in the anterior neural plateNeural Development, 2008
- Vascular calcifications, vertebral fractures and mortality in haemodialysis patientsNephrology Dialysis Transplantation, 2008
- LRP6 Mutation in a Family with Early Coronary Disease and Metabolic Risk FactorsScience, 2007
- Regulation of bone mass by Wnt signalingJCI Insight, 2006